Tag: Cancer: Skin
Adjuvant Pembrolizumab Cuts Recurrence in Stage II Melanoma
Compared with placebo, pembrolizumab prolonged regression-free survival in resected high-risk stage IIB and IIC melanoma
Previous Tx in Metastatic Melanoma May Cut Response to ACT TIL
Prior therapy linked to lower objective response rate to adoptive cell transfer with tumor-infiltrating lymphocytes compared with no prior therapy
Fewer Cancers Might Be Missed With Full-Body Skin Examinations
Authors recommend that dermatologists perform a total-body skin examination even when a patient is referred for a suspicious lesion
Cutaneous Beta-HPV May Up Risk for Cutaneous Squamous Cell Carcinoma
Beta-HPV detected in skin swabs may predict cuSCC risk, but no link seen for serologic evidence of past beta-HPV infection
Remetinostat Gel Promising for Basal Cell Carcinoma
Overall response rate of 69.7 percent seen with topical HDAC inhibitor; complete resolution observed for 54.8 percent of tumors on pathologic exam
Certain Dermoscopic Structures Linked to Melanoma Detection
Odds for melanoma detection highest for presence of white structures, pseudopods, irregular pigmentation, blue-white veil, and peppering
Poll: Many ‘High-Risk’ Americans Unconcerned About Skin Cancer
AAD survey revealed that 49 percent of respondents were more worried about avoiding sunburn than preventing skin cancer
Barriers to Physician Skin Exam ID’d for Young Melanoma Survivors
Barriers to health care access linked to increased odds of suboptimal physician skin examination adherence
Second-Opinion Strategy Analyzed for Cutaneous Melanocytic Lesions
Decision-analytic model shows selective second-opinion strategy could increase diagnostic accuracy, decrease population-level costs
Many Americans Wrong About Sun’s Skin Cancer Dangers: Poll
Survey results show Generation Z and millennials have the greatest misunderstandings about sun exposure